The relation between endometriosis and ovarian cancer - A review

Acta Obstetricia et Gynecologica Scandinavica

Volumn 93, Issue 1, 2014, Pages 20-31

  Heidemann, Lene N ^a   Hartwell, Dorthe ^b   Heidemann, Christian H ^c   Jochumsen, Kirsten M ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Endometriosis; meta analysis; ovarian cancer; review; risk

Indexed keywords

CANCER PATIENT; CASE CONTROL STUDY; CHECKLIST; CLEAR CELL CARCINOMA; CLINICAL ASSESSMENT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOMETRIOSIS; HEALTH CARE QUALITY; HISTOPATHOLOGY; HUMAN; KNOWLEDGE; LAPAROSCOPY; LAPAROTOMY; MEDLINE; META ANALYSIS; MULTICENTER STUDY (TOPIC); OUTCOME VARIABLE; OVARY CANCER; OVARY CARCINOMA; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; REVIEW; RISK FACTOR; SAMPLE SIZE; SIGN CHECKLIST; STANDARDIZED INCIDENCE RATIO; SYSTEMATIC REVIEW;

ENDOMETRIOSIS; META-ANALYSIS; OVARIAN CANCER; REVIEW; RISK;

ENDOMETRIOSIS; FEMALE; HUMANS; INCIDENCE; OVARIAN NEOPLASMS; PREVALENCE; RISK;

EID: 84890564672     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12255     Document Type: Review

References (71)

1. Cancer stat fact sheets. Nordic countries-ovary etc. http://www-dep.iarc. fr/NORDCAN/DK/frame.asp. Available online at: http://www-dep.iarc.fr/NORDCAN/ English/StatsFact.asp?cancer=222&country=0 (accessed December 14, 2011).
2. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics. CA Cancer J Clin. 2010; 60: 277-300.
3. Mok SC, Kwong J, Welch WR, Samimi G, Ozbun L, Bonome T, et al. Etiology and pathogenesis of epithelial ovarian cancer. Dis Markers. 2007; 23: 367-76.
4. Surveillance epidemiology and end results-Table 21.16 cancer of ovary (invasive). Available online at: http://seer.cancer.gov/csr/1975-2010/browse- csr.php?section=21&page=sect-21-table.16.html (accessed 16 May, 2011).
5. Vercellini P, Scarfone G, Bolis G, Stellato G, Carinelli S, Crosignani PG,. Site of origin of epithelial ovarian cancer: the endometriosis connection. Br J Obstet Gynaecol. 2000; 107: 1155-7.
6. Brinton LA, Sakoda LC, Sherman ME, Frederiksen K, Kjaer SK, Graubard BI, et al. Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2929-35.
7. Aris A,. Endometriosis-associated ovarian cancer: a ten-year cohort study of women living in the Estrie Region of Quebec, Canada. J Ovarian Res. 2010; 3: 2.
8. Heaps JM, Nieberg RK, Berek JS,. Malignant neoplasms arising in endometriosis. Obstet Gynecol. 1990; 75: 1023-8.
9. Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T, et al. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer. 2007; 17: 37-43.
10. Ogawa S, Kaku T, Amada S, Kobayashi H, Hirakawa T, Ariyoshi K, et al. Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol. 2000; 77: 298-304.
11. Sainz de la Cuesta R, Eichhorn JH, Rice LW, Fuller AF Jr, Nikrui N, Goff BA,. Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol Oncol. 1996; 60: 238-44.
12. Olive DL, Schwartz LB,. Endometriosis. N Engl J Med. 1993; 328: 1759-69.
13. Stern RC, Dash R, Bentley RC, Snyder MJ, Haney AF, Robboy SJ,. Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol. 2001; 20: 133-9.
14. Berkley KJ, Rapkin AJ, Papka RE,. The pains of endometriosis. Science. 2005; 308: 1587-9.
15. Gazvani R, Templeton A,. New considerations for the pathogenesis of endometriosis. Int J Gynaecol Obstet. 2002; 76: 117-26.
16. Adamson GD,. Diagnosis and clinical presentation of endometriosis. Am J Obstet Gynecol. 1990; 162: 568-9.
17. Maiorana A, Cicerone C, Niceta M, Alio L,. Evaluation of serum CA 125 levels in patients with pelvic pain related to endometriosis. Int J Biol Markers. 2007; 22: 200-2.
18. Lim MC, Lee DO, Kang S, Seo SS, Lee BY, Park SY,. Clinical manifestations in patients with ovarian clear cell carcinoma with or without co-existing endometriosis. Gynecol Endocrinol. 2009; 25: 435-40.
19. Sampson JA,. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg. 1925; 10: 1-72.
20. Scott RB,. Malignant changes in endometriosis. Obstet Gynecol. 1953; 2: 283-9.
21. LaGrenade A, Silverberg SG,. Ovarian tumors associated with atypical endometriosis. Hum Pathol. 1988; 19: 1080-4.
22. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010; 363: 1532-43.
23. Bischoff FZ, Heard M, Simpson JL,. Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis. J Reprod Immunol. 2002; 55: 49-64.
24. Fukunaga M, Nomura K, Ishikawa E, Ushigome S,. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology. 1997; 30: 249-55.
25. Jimbo H, Hitomi Y, Yoshikawa H, Yano T, Momoeda M, Sakamoto A, et al. Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts. Am J Pathol. 1997; 150: 1173-8.
26. Jiang X, Hitchcock A, Bryan EJ, Watson RH, Englefield P, Thomas EJ, et al. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res. 1996; 56: 3534-9.
27. Wu Y, Basir Z, Kajdacsy-Balla A, Strawn E, Macias V, Montgomery K, et al. Resolution of clonal origins for endometriotic lesions using laser capture microdissection and the human androgen receptor (HUMARA) assay. Fertil Steril. 2003; 79 (Suppl 1): 710-7.
28. Ness RB,. Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol. 2003; 189: 280-94.
29. O'Byrne KJ, Dalgleish AG,. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer. 2001; 85: 473-83.
30. Taylor RN, Ryan IP, Moore ES, Hornung D, Shifren JL, Tseng JF,. Angiogenesis and macrophage activation in endometriosis. Ann N Y Acad Sci. 1997; 828: 194-207.
31. Critical appraisal: notes and checklists. Available online at: http://www.sign.ac.uk/methodology/checklists.html (accessed September 16, 2011).
32. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-60.
33. Borgfeldt C, Andolf E,. Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand. 2004; 83: 395-400.
34. Merritt MA, Green AC, Nagle CM, Webb PM,. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer. 2008; 122: 170-6.
35. Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Althuis MD, Mabie JE, et al. Causes of infertility as predictors of subsequent cancer risk. Epidemiology. 2005; 16: 500-7.
36. Kontoravdis A, Augoulea A, Lambrinoudaki I, Christodoulakos G, Tzortziotis D, Grammatikakis I, et al. Ovarian endometriosis associated with ovarian cancer and endometrial-endocervical polyps. J Obstet Gynaecol Res. 2007; 33: 294-8.
37. Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril. 2004; 82: 405-14.
38. Melin A, Sparen P, Persson I, Bergqvist A,. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod. 2006; 21: 1237-42.
39. Punnonen R, Klemi PJ, Nikkanen V,. Postmenopausal endometriosis. Eur J Obstet Gynecol Reprod Biol. 1980; 11: 195-200.
40. Surprasert P, Khunamornpong S, Srisomboon J,. Clinicopathological features and prognosis of Thai women with endometrioisis-associated ovarian carcinoma. Asian Pac J Cancer Prev. 2006; 7: 638-40.
41. Nishida M, Watanabe K, Sato N, Ichikawa Y,. Malignant transformation of ovarian endometriosis. Gynecol Obstet Invest. 2000; 50 (Suppl 1): 18-25.
42. Deligdisch L, Penault-Llorca F, Schlosshauer P, Altchek A, Peiretti M, Nezhat F,. Stage I ovarian carcinoma: different clinical pathologic patterns. Fertil Steril. 2007; 88: 906-10.
43. Melin A, Lundholm C, Malki N, Swahn ML, Sparen P, Bergqvist A,. Endometriosis as a prognostic factor for cancer survival. Int J Cancer. 2010; 129: 949-55.
44. Wang S, Qiu L, Lang JH, Shen K, Huang HF, Pan LY, et al. Prognostic analysis of endometrioid epithelial ovarian cancer with or without endometriosis: a 12-year cohort study of Chinese patients. Am J Obstet Gynecol. 2013; 209: 241.e1-9.
45. Kumar S, Munkarah A, Arabi H, Bandyopadhyay S, Semaan A, Hayek K, et al. Prognostic analysis of ovarian cancer associated with endometriosis. Am J Obstet Gynecol. 2011; 204: 63-7.
46. Orezzoli JP, Russell AH, Oliva E, Del Carmen MG, Eichhorn J, Fuller AF,. Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Gynecol Oncol. 2008; 110: 336-44.
47. Noli S, Cipriani S, Scarfone G, Villa A, Grossi E, Monti E, et al. Long term survival of ovarian endometriosis associated clear cell and endometrioid ovarian cancers. Int J Gynecol Cancer. 2013; 23: 244-8.
48. Cuff J, Longacre TA,. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type. Am J Surg Pathol. 2012; 36: 688-95.
49. Melin A, Lundholm C, Malki N, Swahn ML, Steinberg SM, Bergqvist A,. Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer. Acta Obstet Gynecol Scand. 2013; 92: 546-54.
50. Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT,. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol. 2004; 191: 733-40.
51. DePriest PD, Banks ER, Powell DE, van Nagell JRJ, Gallion HH, Puls LE, et al. Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women. Gynecol Oncol. 1992; 47: 71-5.
52. Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS,. Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control. 2008; 19: 1357-64.
53. Clement PB,. The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects. Adv Anat Pathol. 2007; 14: 241-60.
54. Diebold J,. Molecular carcinogenesis of ovarian carcinoma. Verh Dtsch Ges Pathol. 2005; 89: 77-83.
55. Goumenou AG, Arvanitis DA, Matalliotakis IM, Koumantakis EE, Spandidos DA,. Microsatellite DNA assays reveal an allelic imbalance in p16(Ink4), GALT, p53, and APOA2 loci in patients with endometriosis. Fertil Steril. 2001; 75: 160-5.
56. Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JP, Lees JA, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst. 2000; 92: 924-30.
57. Obata K, Hoshiai H,. Common genetic changes between endometriosis and ovarian cancer. Gynecol Obstet Invest. 2000; 50 (Suppl 1): 39-43.
58. Sainz de la Cuesta R, Izquierdo M, Canamero M, Granizo JJ, Manzarbeitia F,. Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2004; 113: 87-93.
59. Watson RH, Neville PJ, Roy WJ Jr, Hitchcock A, Campbell IG,. Loss of heterozygosity on chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis. Oncogene. 1998; 17: 207-12.
60. Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 2000; 60: 7052-6.
61. Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol. 2012; 13: 385-94.
62. Fukunaga M, Ushigome S,. Epithelial metaplastic changes in ovarian endometriosis. Mod Pathol. 1998; 11: 784-8.
63. Aure JC, Hoeg K, Kolstad P,. Carcinoma of the ovary and endometriosis. Acta Obstet Gynecol Scand. 1971; 50: 63-7.
64. Brescia RJ, Dubin N, Demopoulos RI,. Endometrioid and clear cell carcinoma of the ovary. Factors affecting survival. Int J Gynecol Pathol. 1989; 8: 132-8.
65. Crozier MA, Copeland LJ, Silva EG, Gershenson DM, Stringer CA,. Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol. 1989; 35: 199-203.
66. Dzatic-Smiljkovic O, Vasiljevic M, Djukic M, Vugdelic R, Vugdelic J,. Frequency of ovarian endometriosis in epithelial ovarian cancer patients. Clin Exp Obstet Gynecol. 2011; 38: 394-8.
67. Jimbo H, Yoshikawa H, Onda T, Yasugi T, Sakamoto A, Taketani Y,. Prevalence of ovarian endometriosis in epithelial ovarian cancer. Int J Gynaecol Obstet. 1997; 59: 245-50.
68. Komiyama S, Aoki D, Tominaga E, Susumu N, Udagawa Y, Nozawa S,. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Gynecol Oncol. 1999; 72: 342-6.
69. Oral E, Ilvan S, Tustas E, Korbeyli B, Bese T, Demirkiran F, et al. Prevalence of endometriosis in malignant epithelial ovary tumours. Eur J Obstet Gynecol Reprod Biol. 2003; 109: 97-101.
70. Terzi A, Aktas IY, Dolgun A, Ayhan A, Kucukali T, Usubutun A,. Early stage epithelial ovarian cancers: a study of morphologic prognostic factors. Pathol Res Pract. 2013; 209: 359-64.
71. Valenzuela P, Ramos P, Redondo S, Cabrera Y, Alvarez I, Ruiz A,. Endometrioid adenocarcinoma of the ovary and endometriosis. Eur J Obstet Gynecol Reprod Biol. 2007; 134: 83-6.